Unnati Pharmax

Slim Trim Active 120mg Capsules
Composition: Orlistat Capsules USP 120mg
International Trade Name: Xenical®

Slim Trim Active 120 is a high-quality Orlistat 120mg Capsules USP, a generic equivalent of the internationally recognized anti-obesity medication marketed under the brand name Xenical®. Manufactured in WHO-GMP certified facilities, Slim Trim Active Capsules are supplied by trusted pharmaceutical exporters from India to support effective global weight management and obesity control programs.

Orlistat is a clinically proven gastrointestinal lipase inhibitor that acts locally in the digestive tract to block the absorption of approximately 30% of dietary fats, thereby reducing caloric intake and supporting sustainable weight loss. Slim Trim Active 120mg Capsules are primarily indicated for the treatment and long-term management of obesity, including weight reduction and weight maintenance, in adults with a BMI ≥30 kg/m² or BMI ≥27 kg/m² with associated comorbidities such as type 2 diabetes mellitus, hypertension, or dyslipidemia. The therapy is recommended as an adjunct to a calorie-restricted, low-fat diet for optimal clinical outcomes.

Orlistat 120mg capsules, Slim Trim Active 120, Xenical generic, anti-obesity capsules, weight loss medication exporter India, lipase inhibitor therapy, BMI management drug, WHO-GMP pharmaceutical manufacturer India.

Slim Trim Active 120 Orlistat Capsules USP are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and shelf stability. The capsules are supplied in tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, obesity clinics, retail pharmacies, wellness centers, government health programs, and international pharmaceutical distributors.

Lirafit Injection
Composition: Liraglutide Injection
International Trade Name: Saxenda®

Lirafit is a high-quality Liraglutide Injection, a biosimilar/generic equivalent of the internationally recognized GLP-1 receptor agonist marketed under the brand name Saxenda®. Manufactured in WHO-GMP certified facilities, Lirafit Injection is supplied by trusted pharmaceutical exporters from India to support advanced global weight management and metabolic disorder treatment programs.

Liraglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist that works by reducing appetite, increasing satiety, and lowering caloric intake, thereby promoting sustained weight loss. Lirafit Injection is primarily indicated for chronic weight management in adults with a BMI ≥30 kg/m² (obese) or BMI ≥27 kg/m² (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia. The therapy is recommended as an adjunct to a reduced-calorie diet and increased physical activity.

Liraglutide injection, Lirafit injection, Saxenda generic, GLP-1 weight loss injection, anti-obesity injectable therapy, appetite suppressant injection, metabolic disorder treatment, biologics exporter India, WHO-GMP injectable manufacturer India.

Lirafit Liraglutide Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, endocrinology and obesity clinics, metabolic care centers, government health programs, and international pharmaceutical distributors.

OStat 120 Capsule
Composition: Orlistat Capsules USP 120mg
International Trade Name: Xenical®

OStat 120 is a high-quality Orlistat 120mg Capsules USP, a generic equivalent of the internationally recognized anti-obesity medication marketed under the brand name Xenical®. Manufactured in WHO-GMP certified facilities, OStat Capsules are supplied by trusted pharmaceutical exporters from India to support effective global weight management and obesity treatment programs.

Orlistat is a well-established gastrointestinal lipase inhibitor that works by inhibiting the absorption of dietary fats in the intestine, thereby reducing overall caloric intake. OStat 120 Capsules are primarily indicated for the management of obesity, including weight reduction and long-term weight maintenance, in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with associated risk factors such as type 2 diabetes mellitus, hypertension, or dyslipidemia. The therapy is recommended as an adjunct to a calorie-controlled, low-fat diet to achieve optimal therapeutic results.

Orlistat 120mg capsules, OStat 120 Capsule, Xenical generic, anti-obesity capsules, weight loss medicine exporter India, lipase inhibitor capsules, BMI management therapy, WHO-GMP pharmaceutical manufacturer India.

OStat 120 Orlistat Capsules USP are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, obesity clinics, retail pharmacies, wellness centers, government health programs, and international pharmaceutical distributors.

Orlica Capsules
Composition: Orlistat Capsules USP 120 mg
International Trade Name: Xenical®

Orlica 120 is a high-quality Orlistat 120 mg Capsules USP, a generic equivalent of the internationally recognized anti-obesity medication marketed under the brand name Xenical®. Manufactured in WHO-GMP certified facilities, Orlica Capsules are supplied by trusted pharmaceutical exporters from India to support effective global weight-management and obesity-treatment programs.

Orlistat is a clinically proven gastrointestinal lipase inhibitor that works by blocking the absorption of dietary fats in the intestine, thereby reducing overall caloric intake and supporting sustainable weight loss. Orlica 120 Capsules are primarily indicated for the treatment and long-term management of obesity, including weight reduction and maintenance, in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with associated risk factors such as type 2 diabetes, hypertension, or dyslipidemia. The medication is recommended as an adjunct to a calorie-controlled, low-fat diet for optimal results.

Orlistat 120 mg capsules, Orlica Capsule 120 mg, Xenical generic, anti-obesity capsules, weight-loss medicine exporter India, lipase inhibitor capsules, obesity management therapy, WHO-GMP pharmaceutical manufacturer India.

Orlica Orlistat Capsules USP are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The capsules are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, obesity and bariatric clinics, retail pharmacies, government health programs, and international pharmaceutical distributors.

Orlica 120 mg Tablets
Composition: Orlistat 120 mg Tablets
International Trade Name: Xenical®

Orlica 120 is a high-quality Orlistat 120 mg Tablet, a therapeutic equivalent of the internationally recognized anti-obesity medication marketed under the brand name Xenical®. Manufactured in WHO-GMP certified facilities, Orlica Tablets are supplied by trusted pharmaceutical exporters from India to support effective weight management programs worldwide, particularly for patients with obesity and obesity-related metabolic disorders.

Orlistat is a potent gastrointestinal lipase inhibitor that works by blocking the absorption of approximately 30% of dietary fat consumed. By preventing fat breakdown and absorption in the intestine, Orlica 120 mg Tablets help reduce overall caloric intake, supporting sustainable weight loss and weight maintenance when used in conjunction with a calorie-controlled diet and lifestyle modifications.

Orlica 120 mg Tablets are primarily indicated for the management of obesity (BMI ≥30 kg/m²) and overweight patients (BMI ≥27 kg/m²) with associated risk factors such as type 2 diabetes, dyslipidemia, hypertension, and cardiovascular disease. The product is suitable for long-term use under medical supervision and is widely utilized in clinical weight management and metabolic health programs.

Orlistat 120 mg tablets, Orlica 120 tablets, Xenical equivalent, anti-obesity medicine, weight loss tablets, fat absorption inhibitor, obesity treatment medication, pharmaceutical exporter India, and WHO-GMP manufacturer India.

Orlica 120 Orlistat Tablets are manufactured under stringent GMP and international pharmaceutical quality standards, ensuring consistent potency, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government health programs, and international pharmaceutical distributors.

Slimtop Orlistat 120mg Capsule
Composition: Orlistat Capsules USP 120mg
International Trade Name: Xenical®

Slimtop Orlistat 120 is a high-quality Orlistat 120mg Capsules USP, a generic equivalent of the internationally recognized anti-obesity medication marketed under the brand name Xenical®. Manufactured in WHO-GMP certified facilities, Slimtop Capsules are supplied by trusted pharmaceutical exporters from India to support effective global weight management and obesity control programs.

Orlistat is a clinically proven gastrointestinal lipase inhibitor that works by blocking the absorption of dietary fats in the intestine, thereby reducing caloric intake and supporting sustainable weight loss. Slimtop Orlistat 120mg Capsules are primarily indicated for the treatment and long-term management of obesity, including weight reduction and weight maintenance, in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with associated risk factors such as type 2 diabetes mellitus, hypertension, or dyslipidemia. The medication is recommended as an adjunct to a calorie-restricted, low-fat diet for optimal therapeutic outcomes.

Orlistat 120mg capsules, Slimtop Orlistat Capsule, Xenical generic, anti-obesity medicine, weight loss capsules exporter India, lipase inhibitor therapy, BMI management drug, WHO-GMP pharmaceutical manufacturer India.

Slimtop Orlistat 120 Capsules USP are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and shelf stability. The capsules are supplied in tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, obesity clinics, retail pharmacies, wellness centers, government health programs, and international pharmaceutical distributors.

SlimTop 60 Tablets
Composition: Orlistat Tablets USP 60mg
International Trade Name: Alli®

SlimTop 60 is a high-quality Orlistat 60mg Tablets USP, a generic equivalent of the internationally recognized over-the-counter weight management product marketed under the brand name Alli®. Manufactured in WHO-GMP certified facilities, SlimTop 60 Tablets are supplied by reliable pharmaceutical exporters from India to support global weight control and obesity prevention programs.

Orlistat is a clinically proven gastrointestinal lipase inhibitor that works by reducing the absorption of dietary fat by approximately 25%, helping to lower overall caloric intake. SlimTop 60 Tablets are primarily indicated for weight loss and weight maintenance in overweight adults with a BMI ≥25 kg/m², when used in combination with a balanced, reduced-calorie, low-fat diet. The lower 60mg strength makes it suitable for OTC-style weight management programs under medical or pharmacist guidance.

Orlistat 60mg tablets, SlimTop 60 tablets, Alli generic, OTC weight loss tablets, lipase inhibitor tablets, obesity management medicine, weight control exporter India, WHO-GMP pharmaceutical manufacturer India.

SlimTop 60 Orlistat Tablets USP are manufactured under stringent GMP and quality compliance standards, ensuring consistent quality, safety, and stability. The tablets are supplied in tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for retail pharmacies, wellness clinics, obesity centers, hospital pharmacies, government health initiatives, and international pharmaceutical distributors.

Orlijohn-120 Capsules
Composition: Orlistat Capsules USP 120mg
International Trade Name: Xenical®

Orlijohn-120 is a high-quality Orlistat 120mg Capsules USP, a generic equivalent of the internationally recognized anti-obesity medication marketed under the brand name Xenical®. Manufactured in WHO-GMP certified facilities, Orlijohn-120 Capsules are supplied by trusted pharmaceutical exporters from India to support effective global weight management and obesity treatment programs.

Orlistat is a potent gastrointestinal lipase inhibitor that works by blocking the absorption of dietary fats in the intestine, thereby reducing overall caloric intake. Orlijohn-120 Capsules are primarily indicated for the management of obesity, including weight loss and long-term weight maintenance, in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with associated risk factors such as type 2 diabetes, hypertension, or dyslipidemia. The medication is recommended as an adjunct to a calorie-controlled, low-fat diet for optimal therapeutic outcomes.

Orlistat 120mg capsules, Orlijohn-120 capsules, Xenical generic, anti-obesity capsules, weight loss medicine exporter India, lipase inhibitor capsules, BMI management therapy, WHO-GMP pharmaceutical manufacturer India.

Orlijohn-120 Orlistat Capsules USP are manufactured under stringent GMP and quality assurance standards, ensuring consistent potency, safety, and stability throughout the product lifecycle. The capsules are supplied in tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, obesity clinics, retail pharmacies, wellness centers, government health programs, and international pharmaceutical distributors.

O-Stat 60 Capsules
Composition: Orlistat Capsules USP 60mg
International Trade Name: Alli®

O-Stat 60 is a high-quality Orlistat 60mg Capsules USP, a generic equivalent of the internationally recognized over-the-counter anti-obesity medication marketed under the brand name Alli®. Manufactured in WHO-GMP certified facilities, O-Stat 60 Capsules are supplied by trusted pharmaceutical exporters from India to support effective global weight management and obesity control programs.

Orlistat is a well-established gastrointestinal lipase inhibitor that works by reducing the absorption of dietary fats in the intestine, thereby lowering overall caloric intake. O-Stat 60 Capsules are primarily indicated for weight loss and weight maintenance in overweight adults with a BMI ≥25 kg/m², when used alongside a calorie-restricted, low-fat diet. The 60mg strength is particularly suitable for OTC-aligned weight management regimens under medical or pharmacist supervision.

Orlistat 60mg capsules, O-Stat 60 capsules, Alli generic, OTC weight loss capsules, lipase inhibitor capsules, obesity management therapy, weight control medicine exporter India, WHO-GMP pharmaceutical manufacturer India.

O-Stat 60 Orlistat Capsules USP are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and product stability. The capsules are supplied in tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for retail pharmacies, wellness and obesity clinics, hospital pharmacies, government health programs, and international pharmaceutical distributors.

Mounjaro Tirzepatide 5mg Solution
Composition: Tirzepatide Injection 5mg
International Trade Name: Mounjaro®

Mounjaro Tirzepatide 5mg Solution is a high-quality Tirzepatide Injection, equivalent to the internationally recognized dual incretin therapy marketed under the brand name Mounjaro®. Manufactured in WHO-GMP certified facilities, this product is supplied by trusted pharmaceutical exporters from India to support advanced global diabetes and metabolic disease management programs.

Tirzepatide is a novel, first-in-class dual GIP and GLP-1 receptor agonist that improves glycemic control by enhancing insulin secretion, reducing glucagon levels, delaying gastric emptying, and promoting appetite regulation. Mounjaro Tirzepatide 5mg Solution is primarily indicated for the treatment of type 2 diabetes mellitus in adults and is widely used to support weight reduction and metabolic improvement in patients with insulin resistance or obesity-related comorbidities. The therapy is administered as a once-weekly subcutaneous injection, offering improved treatment adherence and convenience.

Tirzepatide 5mg injection, Mounjaro generic, dual GIP GLP-1 agonist, type 2 diabetes injection, metabolic disorder treatment, weight management therapy, injectable antidiabetic exporter India, WHO-GMP biologics manufacturer India.

Mounjaro Tirzepatide 5mg Solution is manufactured under stringent GMP and sterile injectable quality standards, ensuring consistent potency, safety, and long-term stability. The product is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, diabetes clinics, endocrinology centers, government health programs, and international pharmaceutical distributors.